LISSUN to expand child mental services

IMT News Desk
IMT News Desk
· 2 min read

The new centres will target cities like Mumbai, Bengaluru, Hyderabad and Chennai

LISSUN, a mental health platform, announced its ambitious plans to expand Sunshine by LISSUN, a specialised division focussed on child development and therapy services. Currently operating nine centres, Sunshine is on track to expand to 40+ centres and reach 8000+ children by the end of 2025.

The expansion is part of LISSUN’s mission to provide high-quality, accessible, and affordable services to children with developmental delays and special needs and help them with issues like  Autism Spectrum Disorder (ASD), ADHD, and Learning Disabilities.

As of January 2025, Sunshine by LISSUN operates in 13 centres across key cities in India, including East Patel Nagar, East of Kailash, and Pitampura in Delhi; Indirapuram in Ghaziabad; Sector 51 & Old Gurugram in Gurugram; Gomti Nagar and Aashiyana in Lucknow; and Magarpatta, Viman Nagar and Hadapsar in Pune, Gachibowli in Hyderabad and Domlur in Bangalore. LISSUN plans to strategically expand Sunshine to 40+ centres by the end of 2025, with a focus on metropolitan areas, educational hubs, and underserved regions.

The new centres will target cities like Bengaluru, Hyderabad, Jaipur and Mumbai, where the demand for child developmental and mental health services is growing. Additionally, the expansion will prioritise cities with a high concentration of schools and educational institutions, facilitating partnerships and referral networks. LISSUN also aims to enter underserved areas in Tier-II and Tier-III cities, where access to quality child developmental services remains limited.

Read Next

Zydus Wellness net sales up by 62.1% for Q4 & 46.4% for FY 26  
News
May 19, 2026

Zydus Wellness net sales up by 62.1% for Q4 & 46.4% for FY 26  

Zydus Wellness Limited reported a consolidated growth of 62.1% in Net Sales, which stood at Rs. 14,761 million as compared to Rs. 9,106 million in the corresponding period of the previous year. The Company reported annual Net Sales of Rs. 39,400 million, with a y-o-y growth of 46.4% in FY 26. EBITDA for the period […]
Article by: IMT News Desk
Strides Pharma delivers strong FY26 performance with 50% PAT growth, ex‑US markets up 21%
News
May 19, 2026

Strides Pharma delivers strong FY26 performance with 50% PAT growth, ex‑US markets up 21%

Strides Pharma Science Ltd. reported a robust FY26 performance, with consolidated EBITDA rising to ₹9,253 crore and operational profit after tax (PAT) at ₹5,181 crore, up 50.3% year‑on‑year. The company’s ex‑US markets outpaced the rest of the business, posting 21% YoY revenue growth, while disciplined execution expanded full‑year EBITDA margin to 19%, up 140 basis points from FY25. […]
Article by: IMT News Desk
Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability
News
May 18, 2026

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability

Annora Pharma, the formulations subsidiary of Hetero Group, has expanded its collaboration with AltiusHub. The company is deploying AltiusHub’s AI-native serialization, track & trace and regulatory compliance platform across its export operations. The deployment is designed to improve serialization efficiency by up to 45%. It will also strengthen operational visibility across Annora Pharma’s global supply […]
Article by: IMT News Desk
WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation
News
May 18, 2026

WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation

The World Federation of Neurosurgical Societies (WFNS) Innovation & Technology Committee has announced collaboration with Time Medical International Ventures (India) Pvt. Ltd (Time Medical India)., a wholly owned subsidiary of Fischer Medical Ventures Limited, marking a significant milestone in advancing innovation in global neurosurgical care. This marks the first time the Committee has formally partnered […]
Article by: IMT News Desk